Jonathan Lovell

PhD

UB Distinguished Professor

Nanomedicine; phototherapy

Buffalo NY, 14260

Phone: (716) 645-1020

Fax: (716) 645-2207

Supporting Innovative Scientists and Breakthrough Discoveries
9/3/25
The American Parkinsons Disease Association announced $4.04 million in new funding for cutting-edge Parkinson’s disease research, which includes support for Jonathan Lovell (BME), who is testing a new type of vaccine.
Research to accelerate vaccine development
7/25/25
Scientist Live reported on the The Coalition for Epidemic Preparedness Innovation awarding POP Biotechnologies, a UB startup co-founded by Jonathan Lovell, $1.5 million for research into making vaccines against epidemic and pandemic threats.
New protein vaccine approach could enable faster responses to Disease X
7/23/25
The Coalition for Epidemic Preparedness Innovations (CEPI) reported that it will provide POP Biotechnologies, a UB startup co-founded by Jonathan Lovell), with $1.5 million for research into making vaccines against epidemic and pandemic threats.
Researchers at the University at Buffalo are working on light-infused treatment
6/20/25
WIVB featured an interview with Jonathan Lovell for his research into a smarter and more effective way to deliver chemotherapy in metastatic pancreatic cancer using light-infused treatment.
Three SEAS faculty receive SUNY Chancellor’s Awards
6/6/25
Paschalis Alexandridis, Jonathan Lovell and Filip Stefanovic have received SUNY Chancellor’s Awards, recognizing their consistently superior professional achievements and ongoing pursuit of excellence.